Arteaus Therapeutics, LLC — Form D/A
Arteaus Therapeutics, LLC of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2012-07-24. The offering totals $18.0M, of which $15.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-07-24
- Form: D/A
- Accession: 0001526753-12-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $18.0M
- Amount sold: $15.6M
- Remaining: $2.4M
- Investors: 3
- Security types: equity
- Revenue range: Decline to Disclose
Issuer
- Name: Arteaus Therapeutics, LLC
- CIK: 0001526753
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 25 FIRST STREET, CAMBRIDGE, MA, 02141
- Phone: 617-588-2600
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Jean-Francois Formela | Director | Cambridge, MA |
| David Grayzel | Director | Cambridge, MA |
| David Grayzel | Executive Officer | Cambridge, MA |
| Thomas Schuetz | Director | Cambridge, MA |
| Jean-Francois Fromela | Director | Cambridge, MA |
Other filings by this issuer (1)
More